Clinical trial
Observational Familial Adenomatous Polyposis Registry Study In Patients…
NCT00151476 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00151476 |
|---|---|
| Title | Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients |
| Official title | A Registry-Based Observational Study Assessing Clinical Outcomes In Familial Adenomatous Polyposis In Patients Receiving Celecoxib (Celebrex(Registered), Onsenal(Registered)) Compared With Control Patients |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Study type | Observational |
| Conditions | Familial Adenomatous Polyposis (FAP) |
| Intervention type | Drug, Other |
| Interventions | Celecoxib, Routine Medical Care |
| Enrollment | 68 |
| Start date | Nov 1, 2004 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Sep 9, 2005 |
| Last update posted | Sep 4, 2024 |
| Countries | Canada, Denmark, Spain, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: